Search research articles
Contact Us
Filters
Showing results (51-60 of 194) with videos related to
Page
of 20
Sort By:
Bulletin Du Cancer
|
July 1, 1997
[A medico-economic evaluation of second line chemotherapy in metastatic breast cancer: comparison between docetaxel, paclitaxel, and vinorelbine]
R J Launois, J M Reboul-Marty, J Bonneterre
European Journal of Cancer & Clinical Oncology
|
November 1, 1986
Correlation between prolactin receptors (PRL R), estradiol (ER) and progesterone receptors (PgR) in human breast cancer
J Bonneterre, J P Peyrat, R Beuscart, et al.
Cancer Research
|
November 1, 1990
Prognostic significance of insulin-like growth factor 1 receptors in human breast cancer
J Bonneterre, J P Peyrat, R Beuscart, et al.
Pharmacoeconomics
|
October 4, 1996
A cost-utility analysis of second-line chemotherapy in metastatic breast cancer. Docetaxel versus paclitaxel versus vinorelbine
R Launois, J Reboul-Marty, B Henry, et al.
Annales D'Immunologie
|
September 1, 1983
Subclass restriction of the antiidiotypic antibody response in the rat
R Rousseaux-Prévost, J Bonneterre, H Bazin, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 1, 1983
Cis-platinum complex with retained prolactin receptor specific binding
B Hecquet, J P Peyrat, J Bonneterre, et al.
Gynecologie, Obstetrique & Fertilite
|
January 5, 2013
[Ki67 in young patients with breast cancer]
F Vasseur, M-C Baranzelli, C Fournier, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
December 20, 1990
Biological and clinical aspects of prolactin receptors (PRL-R) in human breast cancer
J Bonneterre, J P Peyrat, R Beuscart, et al.
Journal of Steroid Biochemistry
|
November 1, 1985
Catecholestrogen binding sites in breast cancer
B Vandewalle, J P Peyrat, J Bonneterre, et al.
LARC Medical
|
January 1, 1982
[Factor analysis: its value in medicine and biology]
R Beuscart, M C Vie, J Bonneterre, et al.
Page
of 20
Search research articles
Search
Showing results (51-60 of 194) with videos related to
Sort By:
Page
of 20
Bulletin Du Cancer
|
July 1, 1997
[A medico-economic evaluation of second line chemotherapy in metastatic breast cancer: comparison between docetaxel, paclitaxel, and vinorelbine]
R J Launois, J M Reboul-Marty, J Bonneterre
European Journal of Cancer & Clinical Oncology
|
November 1, 1986
Correlation between prolactin receptors (PRL R), estradiol (ER) and progesterone receptors (PgR) in human breast cancer
J Bonneterre, J P Peyrat, R Beuscart, et al.
Cancer Research
|
November 1, 1990
Prognostic significance of insulin-like growth factor 1 receptors in human breast cancer
J Bonneterre, J P Peyrat, R Beuscart, et al.
Pharmacoeconomics
|
October 4, 1996
A cost-utility analysis of second-line chemotherapy in metastatic breast cancer. Docetaxel versus paclitaxel versus vinorelbine
R Launois, J Reboul-Marty, B Henry, et al.
Annales D'Immunologie
|
September 1, 1983
Subclass restriction of the antiidiotypic antibody response in the rat
R Rousseaux-Prévost, J Bonneterre, H Bazin, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 1, 1983
Cis-platinum complex with retained prolactin receptor specific binding
B Hecquet, J P Peyrat, J Bonneterre, et al.
Gynecologie, Obstetrique & Fertilite
|
January 5, 2013
[Ki67 in young patients with breast cancer]
F Vasseur, M-C Baranzelli, C Fournier, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
December 20, 1990
Biological and clinical aspects of prolactin receptors (PRL-R) in human breast cancer
J Bonneterre, J P Peyrat, R Beuscart, et al.
Journal of Steroid Biochemistry
|
November 1, 1985
Catecholestrogen binding sites in breast cancer
B Vandewalle, J P Peyrat, J Bonneterre, et al.
LARC Medical
|
January 1, 1982
[Factor analysis: its value in medicine and biology]
R Beuscart, M C Vie, J Bonneterre, et al.
Page
of 20